{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:47:00Z","timestamp":1790444820695,"version":"4.1.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10787-025-01913-9","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T05:23:54Z","timestamp":1755581034000},"page":"5257-5271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Regulation of toll-like receptor signaling pathways in age-related eye disease: from mechanisms to targeted therapeutics"],"prefix":"10.1007","volume":"33","author":[{"given":"Qiaoqiao","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2119-0925","authenticated-orcid":false,"given":"Xuejing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"1913_CR1","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.3390\/ijms22084185","volume":"22","author":"H Ahmed","year":"2021","unstructured":"Ahmed H, Khan MA, Kahlert UD, Niemel\u00e4 M, H\u00e4nggi D, Chaudhry SR et al (2021) Role of adaptor protein myeloid differentiation 88 (MyD88) in post-subarachnoid hemorrhage inflammation: a systematic review. Int J Mol Sci 22:4185","journal-title":"Int J Mol Sci"},{"key":"1913_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4183\/aeb.2019.32","volume":"15","author":"C Aioanei","year":"2019","unstructured":"Aioanei C, Ilies R, Bala C, Petrisor M, Porojan M, Popp R et al (2019) The role of adiponectin and toll-like receptor 4 gene polymorphisms on non-proliferative retinopathy in type 2 diabetes mellitus patients. A case-control study in Romanian Caucasians patients. Acta Endocrinologica (Bucharest) 15:32","journal-title":"Acta Endocrinologica (Bucharest)"},{"key":"1913_CR3","doi-asserted-by":"publisher","first-page":"6616","DOI":"10.19082\/6616","volume":"10","author":"S Bamdad","year":"2018","unstructured":"Bamdad S, Bolkheir A, Sedaghat MR, Motamed M (2018) Changes in corneal thickness and corneal endothelial cell density after phacoemulsification cataract surgery: a double-blind randomized trial. Electron Physician 10:6616","journal-title":"Electron Physician"},{"key":"1913_CR4","first-page":"5594","volume":"47","author":"S Barabino","year":"2006","unstructured":"Barabino S, Rolando M, Bonini S, Mingari C, Moretti S, Micera A et al (2006) Toll\u2013like receptor (TLR) 2 and TLR4 expression in dry eye. Invest Ophthalmol vis Sci 47:5594\u20135594","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR5","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1007\/s00417-024-06529-3","volume":"262","author":"\u0130 Baytaro\u011flu","year":"2024","unstructured":"Baytaro\u011flu \u0130, Baytaro\u011flu MU, Baytaro\u011flu A, Toros MU, Daldal H (2024) Incidence of diabetic retinopathy in anti-TNF treated rheumatic disease patients with type 2 diabetes. Graefes Arch Clin Exp Ophthalmol 262:3559\u20133565","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1913_CR6","doi-asserted-by":"publisher","first-page":"9914854","DOI":"10.1155\/2021\/9914854","volume":"2021","author":"P Behzadi","year":"2021","unstructured":"Behzadi P, Garc\u00eda-Perdomo HA, Karpi\u0144ski TM (2021) Toll-like receptors: general molecular and structural biology. J Immunol Res 2021:9914854","journal-title":"J Immunol Res"},{"key":"1913_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.humimm.2008.12.003","volume":"70","author":"M Buraczynska","year":"2009","unstructured":"Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, Ksiazek A (2009) Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Hum Immunol 70:121\u2013124","journal-title":"Hum Immunol"},{"key":"1913_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.diabres.2016.04.002","volume":"116","author":"M Buraczynska","year":"2016","unstructured":"Buraczynska M, Zukowski P, Ksiazek K, Wacinski P, Dragan M (2016) The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients. Diabetes Res Clin Pract 116:7\u201313","journal-title":"Diabetes Res Clin Pract"},{"key":"1913_CR9","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.3390\/ijms222111876","volume":"22","author":"EM Byrne","year":"2021","unstructured":"Byrne EM, Llori\u00e1n-Salvador M, Lyons TJ, Chen M, Xu H (2021) Tofacitinib ameliorates retinal vascular leakage in a murine model of diabetic retinopathy with type 2 diabetes. Int J Mol Sci 22:11876","journal-title":"Int J Mol Sci"},{"key":"1913_CR10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/cells9051183","volume":"9","author":"S-F Chang","year":"2020","unstructured":"Chang S-F, Chen C-N, Lin J-C, Wang H-E, Mori S, Li J-J et al (2020) Truncated pneumolysin from Streptococcus pneumoniae as a TLR4-antagonizing new drug for chronic inflammatory conditions. Cells 9:1183","journal-title":"Cells"},{"key":"1913_CR11","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3892\/mmr.2016.4890","volume":"13","author":"L Chen","year":"2016","unstructured":"Chen L, Bai Y, Zhao M, Jiang Y (2016) Tlr4 inhibitor attenuates amyloid-\u03b2-induced angiogenic and inflammatory factors in ARPE-19 cells: implications for age-related macular degeneration. Mol Med Rep 13:3249\u20133256","journal-title":"Mol Med Rep"},{"key":"1913_CR12","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.1038\/s41598-023-34673-z","volume":"13","author":"S-C Chi","year":"2023","unstructured":"Chi S-C, Kang Y-N, Huang Y-M (2023) Efficacy and safety profile of intravitreal dexamethasone implant versus antivascular endothelial growth factor treatment in diabetic macular edema: a systematic review and meta-analysis. Sci Rep 13:7428","journal-title":"Sci Rep"},{"key":"1913_CR13","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1167\/iovs.09-3688","volume":"50","author":"Y Cho","year":"2009","unstructured":"Cho Y, Wang JJ, Chew EY, Ferris FL, Mitchell P, Chan C-C et al (2009) Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case\u2013control samples. Invest Ophthalmol vis Sci 50:5614\u20135618","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR14","first-page":"3049","volume":"56","author":"J Courson","year":"2015","unstructured":"Courson J, Lema C, Redfern RL (2015) The role of toll-like receptors in experimental dry eye inflammation. Invest Ophthalmol vis Sci 56:3049\u20133049","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cyto.2015.02.025","volume":"74","author":"D DE Nardo","year":"2015","unstructured":"DE Nardo D (2015) Toll-like receptors: activation, signalling and transcriptional modulation. Cytokine 74:181\u2013189","journal-title":"Cytokine"},{"key":"1913_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1167\/iovs.07-0656","volume":"49","author":"DD Despriet","year":"2008","unstructured":"Despriet DD, Bergen AA, Merriam JE, Zernant J, Barile GR, Smith RT et al (2008) Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration. Invest Ophthalmol vis Sci 49:364\u2013371","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR17","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1167\/iovs.18-25822","volume":"60","author":"A di Zazzo","year":"2019","unstructured":"di Zazzo A, Micera A, Coassin M, Varacalli G, Foulsham W, de Piano M et al (2019a) Inflammaging at ocular surface: clinical and biomolecular analyses in healthy volunteers. Invest Ophthalmol vis Sci 60:1769\u20131775","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR18","doi-asserted-by":"publisher","first-page":"9982","DOI":"10.1002\/jcp.27895","volume":"234","author":"A di Zazzo","year":"2019","unstructured":"di Zazzo A, Micera A, de Piano M, Cortes M, Bonini S (2019b) Tears and ocular surface disorders: usefulness of biomarkers. J Cell Physiol 234:9982\u20139993","journal-title":"J Cell Physiol"},{"key":"1913_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri2471","volume":"9","author":"K Dorshkind","year":"2009","unstructured":"Dorshkind K, Montecino-Rodriguez E, Signer RA (2009) The ageing immune system: is it ever too old to become young again? Nat Rev Immunol 9:57\u201362","journal-title":"Nat Rev Immunol"},{"key":"1913_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","volume":"13","author":"T Duan","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang RF (2022) Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol 13:812774","journal-title":"Front Immunol"},{"key":"1913_CR21","first-page":"1907","volume":"16","author":"G Dvoriantchikova","year":"2010","unstructured":"Dvoriantchikova G, Barakat DJ, Hernandez E, Shestopalov VI, Ivanov D (2010) Toll-like receptor 4 contributes to retinal ischemia\/reperfusion injury. Mol vis 16:1907","journal-title":"Mol vis"},{"key":"1913_CR22","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1111\/ejn.13383","volume":"44","author":"G Dvoriantchikova","year":"2016","unstructured":"Dvoriantchikova G, Pappas S, Luo X, Ribeiro M, Danek D, Pelaez D et al (2016) Virally delivered, constitutively active NF \u03baB improves survival of injured retinal ganglion cells. Eur J Neurosci 44:2935\u20132943","journal-title":"Eur J Neurosci"},{"key":"1913_CR23","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.ajpath.2017.06.015","volume":"187","author":"L Feng","year":"2017","unstructured":"Feng L, Ju M, Lee KYV, Mackey A, Evangelista M, Iwata D et al (2017) A proinflammatory function of toll-like receptor 2 in the retinal pigment epithelium as a novel target for reducing choroidal neovascularization in age-related macular degeneration. Am J Pathol 187:2208\u20132221","journal-title":"Am J Pathol"},{"key":"1913_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s40135-013-0037-x","volume":"2","author":"PA Frederick","year":"2014","unstructured":"Frederick PA, Kleinman ME (2014) The immune system and AMD. Curr Ophthalmol Rep 2:14\u201319","journal-title":"Curr Ophthalmol Rep"},{"key":"1913_CR25","first-page":"1012","volume":"64","author":"E Geiduschek","year":"2023","unstructured":"Geiduschek E, Mavlyutov T, McDowell CM (2023) Toll-like receptor 4 dependent glaucomatous retinal and optic nerve head damage. Invest Ophthalmol vis Sci 64:1012\u20131012","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117935","volume":"256","author":"L Guan","year":"2020","unstructured":"Guan L, Li C, Zhang Y, Gong J, Wang G, Tian P et al (2020) Puerarin ameliorates retinal ganglion cell damage induced by retinal ischemia\/reperfusion through inhibiting the activation of TLR4\/NLRP3 inflammasome. Life Sci 256:117935","journal-title":"Life Sci"},{"key":"1913_CR27","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3109\/02713683.2015.1067326","volume":"41","author":"M G\u00fcven","year":"2016","unstructured":"G\u00fcven M, Batar B, Mutlu T, BOSTANC\u0131 M, Mete M, Aras C et al (2016) Toll-like receptors 2 and 4 polymorphisms in age-related macular degeneration. Curr Eye Res 41:856\u2013861","journal-title":"Curr Eye Res"},{"key":"1913_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110273","volume":"128","author":"X Han","year":"2020","unstructured":"Han X, Chen X, Chen S, Luo Q, Liu X, He A et al (2020) Tetramethylpyrazine attenuates endotoxin-induced retinal inflammation by inhibiting microglial activation via the TLR4\/NF-\u03baB signalling pathway. Biomed Pharmacother 128:110273","journal-title":"Biomed Pharmacother"},{"key":"1913_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41586-020-2282-0","volume":"581","author":"LX Heinz","year":"2020","unstructured":"Heinz LX, Lee J, Kapoor U, Kartnig F, Sedlyarov V, Papakostas K et al (2020) TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7\u20139. Nature 581:316\u2013322","journal-title":"Nature"},{"key":"1913_CR30","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1167\/iovs.16-21331","volume":"58","author":"H Hernandez","year":"2017","unstructured":"Hernandez H, Medina-Ortiz WE, Luan T, Clark AF, McDowell CM (2017) Crosstalk between transforming growth factor beta-2 and toll-like receptor 4 in the trabecular meshwork. Invest Ophthalmol vis Sci 58:1811\u20131823","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR31","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.7150\/thno.104752","volume":"15","author":"T Hu","year":"2025","unstructured":"Hu T, Meng S, Liu C, Fang W, Xia Z, Hu Y et al (2025) LCN2 deficiency mitigates the neuroinflammatory damage following acute glaucoma. Theranostics 15:2967","journal-title":"Theranostics"},{"key":"1913_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100985","volume":"9","author":"J-D Huang","year":"2014","unstructured":"Huang J-D, Amaral J, Lee JW, Rodriguez IR (2014) 7-ketocholesterol-induced inflammation signals mostly through the TLR4 receptor both in vitro and in vivo. PLoS ONE 9:e100985","journal-title":"PLoS ONE"},{"key":"1913_CR33","first-page":"116","volume":"62","author":"N Iranshahi","year":"2016","unstructured":"Iranshahi N, Zafari P, Yari K, Alizadeh E (2016) The most common genes involved in epigenetics modifications among Iranian patients with breast cancer: a systematic review. Cell Mol Biol 62:116\u2013122","journal-title":"Cell Mol Biol"},{"key":"1913_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03003","volume":"10","author":"J Ji","year":"2019","unstructured":"Ji J, Liao Z, Rao Y, Li W, Yang C, Yuan G et al (2019) Thoroughly remold the localization and signaling pathway of TLR22. Front Immunol 10:3003","journal-title":"Front Immunol"},{"key":"1913_CR35","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1111\/j.1755-3768.2012.02414.x","volume":"90","author":"JB Jonas","year":"2012","unstructured":"Jonas JB, Tao Y, Neumaier M, Findeisen P (2012) Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol 90:e381\u2013e388","journal-title":"Acta Ophthalmol"},{"key":"1913_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrrheum.2016.61","volume":"12","author":"LA Joosten","year":"2016","unstructured":"Joosten LA, Abdollahi-Roodsaz S, Dinarello CA, O\u2019neill L, Netea MG (2016) Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol 12:344\u2013357","journal-title":"Nat Rev Rheumatol"},{"key":"1913_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol 5:461","journal-title":"Front Immunol"},{"key":"1913_CR38","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2214-109X(21)00008-5","volume":"9","author":"S Keel","year":"2021","unstructured":"Keel S, Cieza A (2021) Rising to the challenge: estimates of the magnitude and causes of vision impairment and blindness. Lancet Glob Health 9:e100\u2013e101","journal-title":"Lancet Glob Health"},{"key":"1913_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/bjo.86.1.84","volume":"86","author":"R Klein","year":"2002","unstructured":"Klein R, Marino EK, Kuller LH, Polak JF, Tracy RP, Gottdiener JS et al (2002) The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol 86:84\u201390","journal-title":"Br J Ophthalmol"},{"key":"1913_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4614-0631-0_1","volume":"723","author":"ME Kleinman","year":"2012","unstructured":"Kleinman ME, Ambati J (2012) A window to innate neuroimmunity: toll-like receptor-mediated cell responses in the retina. Retinal Degenerat Diseases 723:3\u20139","journal-title":"Retinal Degenerat Diseases"},{"key":"1913_CR41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature06765","volume":"452","author":"ME Kleinman","year":"2008","unstructured":"Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ et al (2008) Sequence-and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452:591\u2013597","journal-title":"Nature"},{"key":"1913_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/mt.2011.212","volume":"20","author":"ME Kleinman","year":"2012","unstructured":"Kleinman ME, Kaneko H, Cho WG, Dridi S, Fowler BJ, Blandford AD et al (2012) Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol Ther 20:101\u2013108","journal-title":"Mol Ther"},{"key":"1913_CR43","doi-asserted-by":"publisher","first-page":"F38","DOI":"10.1152\/ajprenal.00590.2010","volume":"302","author":"C K\u00fcper","year":"2012","unstructured":"K\u00fcper C, Beck F-X, Neuhofer W (2012) Toll-like receptor 4 activates NF-\u03baB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells. Am J Physiol-Renal Physiol 302:F38\u2013F46","journal-title":"Am J Physiol-Renal Physiol"},{"key":"1913_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2015.03.002","volume":"64","author":"J-J Lee","year":"2015","unstructured":"Lee J-J, Wang P-W, Yang I-H, Wu C-L, Chuang J-H (2015) Amyloid-beta mediates the receptor of advanced glycation end product-induced pro-inflammatory response via toll-like receptor 4 signaling pathway in retinal ganglion cell line RGC-5. Int J Biochem Cell Biol 64:1\u201310","journal-title":"Int J Biochem Cell Biol"},{"key":"1913_CR45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/1570159X15666170601125139","volume":"16","author":"M Li","year":"2018","unstructured":"Li M, Liu J, Bi Y, Chen J, Zhao L (2018) Potential medications or compounds acting on toll-like receptors in cerebral ischemia. Curr Neuropharmacol 16:160\u2013175","journal-title":"Curr Neuropharmacol"},{"key":"1913_CR46","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bbi.2020.10.007","volume":"91","author":"L Li","year":"2021","unstructured":"Li L, Acioglu C, Heary RF, Elkabes S (2021) Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun 91:740\u2013755","journal-title":"Brain Behav Immun"},{"key":"1913_CR47","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.bbrc.2017.08.085","volume":"493","author":"Y-R Liao","year":"2017","unstructured":"Liao Y-R, Li Z-J, Zeng P, Lan Y-Q (2017) TLR7 deficiency contributes to attenuated diabetic retinopathy via inhibition of inflammatory response. Biochem Biophys Res Commun 493:1136\u20131142","journal-title":"Biochem Biophys Res Commun"},{"key":"1913_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015583","volume":"98","author":"Y Ling","year":"2019","unstructured":"Ling Y, Xiong F (2019) Associations of TLR4 gene polymorphisms with the risk of age-related macular degeneration in a Chinese Han population. Medicine (Baltimore) 98:e15583","journal-title":"Medicine (Baltimore)"},{"key":"1913_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12016-013-8402-y","volume":"47","author":"Y Liu","year":"2014","unstructured":"Liu Y, Yin H, Zhao M, Lu Q (2014) TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol 47:136\u2013147","journal-title":"Clin Rev Allergy Immunol"},{"key":"1913_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12886-023-02950-0","volume":"23","author":"M Liu","year":"2023","unstructured":"Liu M, Hu F, Lei C, Fu M, Li X, Yu L (2023) Candidate genes identification and RNA-seq based pathway analysis associated with primary angle-closure glaucoma with cataract. BMC Ophthalmol 23:192","journal-title":"BMC Ophthalmol"},{"key":"1913_CR51","doi-asserted-by":"publisher","first-page":"30210","DOI":"10.1074\/jbc.M113.490946","volume":"288","author":"M Loiarro","year":"2013","unstructured":"Loiarro M, Volpe E, Ruggiero V, Gallo G, Furlan R, Maiorino C et al (2013) Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells. J Biol Chem 288:30210\u201330222","journal-title":"J Biol Chem"},{"key":"1913_CR52","doi-asserted-by":"publisher","first-page":"19718","DOI":"10.1038\/srep19718","volume":"6","author":"L Ma","year":"2016","unstructured":"Ma L, Tang FY, Chu WK, Young AL, Brelen ME, Pang CP et al (2016) Association of toll-like receptor 3 polymorphism rs3775291 with age-related macular degeneration: a systematic review and meta-analysis. Sci Rep 6:19718","journal-title":"Sci Rep"},{"key":"1913_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.exer.2013.10.017","volume":"116","author":"CM McDowell","year":"2013","unstructured":"McDowell CM, Tebow HE, Wordinger RJ, Clark AF (2013) Smad3 is necessary for transforming growth factor-beta2 induced ocular hypertension in mice. Exp Eye Res 116:419\u2013423","journal-title":"Exp Eye Res"},{"key":"1913_CR54","first-page":"574","volume":"18","author":"H Miao","year":"2012","unstructured":"Miao H, Tao Y, Li XX (2012) Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol vis 18:574\u2013580","journal-title":"Mol vis"},{"key":"1913_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00417-013-2540-z","volume":"252","author":"A Micera","year":"2014","unstructured":"Micera A, Jirsova K, Normando EM, Stampachiacchiere B, Esposito G, Lambiase A et al (2014) Molecular and biochemical expression of TLRs in human amniotic membrane: a comparative study of fresh and cryopreserved specimens. Graefes Arch Clin Exp Ophthalmol 252:267\u2013274","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1913_CR56","first-page":"39","volume":"7","author":"A Mirshahi","year":"2012","unstructured":"Mirshahi A, Hoehn R, Lorenz K, Kramann C, Baatz H (2012) Anti-tumor necrosis factor alpha for retinal diseases: current knowledge and future concepts. J Ophthalmic vis Res 7:39\u201344","journal-title":"J Ophthalmic vis Res"},{"key":"1913_CR57","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY (2018) Age-related macular degeneration. Lancet 392:1147\u20131159","journal-title":"Lancet"},{"key":"1913_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s40001-025-02404-x","volume":"30","author":"K Moghib","year":"2025","unstructured":"Moghib K, Shivashankar T, Abunamoos A, Mia AH, Salomon I, Ghanm T et al (2025) Efficacy and safety of dexamethasone versus intravitreal aflibercept implants for macular edema: a systematic review and meta-analysis. Eur J Med Res 30:273","journal-title":"Eur J Med Res"},{"key":"1913_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12771","volume":"90","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee S, Huda S, Sinha Babu SP (2019) Toll-like receptor polymorphism in host immune response to infectious diseases: a review. Scand J Immunol 90:e12771","journal-title":"Scand J Immunol"},{"key":"1913_CR60","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jphs.2017.02.012","volume":"133","author":"Y Nakano","year":"2017","unstructured":"Nakano Y, Shimazawa M, Ojino K, Izawa H, Takeuchi H, Inoue Y et al (2017) Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice. J Pharmacol Sci 133:176\u2013183","journal-title":"J Pharmacol Sci"},{"key":"1913_CR61","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1111\/bph.14438","volume":"176","author":"KP Nunes","year":"2019","unstructured":"Nunes KP, de Oliveira AA, Mowry FE, Biancardi VC (2019) Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension? Br J Pharmacol 176:1864\u20131879","journal-title":"Br J Pharmacol"},{"key":"1913_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.immuni.2008.06.004","volume":"29","author":"LA O'neill","year":"2008","unstructured":"O\u2019neill LA (2008) When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29:12\u201320","journal-title":"Immunity"},{"key":"1913_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1023\/B:INTE.0000018524.48581.79","volume":"25","author":"AA Ozcan","year":"2004","unstructured":"Ozcan AA, Ozdemir N, Canataroglu A (2004) The aqueous levels of TGF-\u03b22 in patients with glaucoma. Int Ophthalmol 25:19\u201322","journal-title":"Int Ophthalmol"},{"key":"1913_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12348-014-0026-8","volume":"4","author":"I Pascual-Camps","year":"2014","unstructured":"Pascual-Camps I, Hern\u00e1ndez-Mart\u00ednez P, Monje-Fern\u00e1ndez L, Dolz-Marco R, Gallego-Pinazo R, Wu L et al (2014) Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders. J Ophthalmic Inflamm Infect 4:26","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1913_CR65","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1128\/CMR.00001-11","volume":"24","author":"C Picard","year":"2011","unstructured":"Picard C, Casanova J-L, Puel A (2011) Infectious diseases in patients with IRAK-4, MyD88, NEMO, or I\u03baB\u03b1 deficiency. Clin Microbiol Rev 24:490\u2013497","journal-title":"Clin Microbiol Rev"},{"key":"1913_CR66","first-page":"2817","volume":"64","author":"A Pollreisz","year":"2023","unstructured":"Pollreisz A, Camino A, Gibson K, Mar F, Shildkrot E, Tang Y et al (2023) Faster time to retinal fluid control with faricimab versus aflibercept in patients with DME in the phase 3 YOSEMITE\/RHINE trials. Invest Ophthalmol vis Sci 64:2817\u20132817","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR67","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/art.20114","volume":"50","author":"TR Radstake","year":"2004","unstructured":"Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, Barrera P et al (2004) The toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and\/or outcome. Arthritis Rheum 50:999\u20131001","journal-title":"Arthritis Rheum"},{"key":"1913_CR68","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.exer.2010.03.012","volume":"90","author":"RL Redfern","year":"2010","unstructured":"Redfern RL, McDermott AM (2010) Toll-like receptors in ocular surface disease. Exp Eye Res 90:679\u2013687","journal-title":"Exp Eye Res"},{"key":"1913_CR69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.exer.2010.12.005","volume":"92","author":"RL Redfern","year":"2011","unstructured":"Redfern RL, Reins RY, McDermott AM (2011) Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells. Exp Eye Res 92:209\u2013220","journal-title":"Exp Eye Res"},{"key":"1913_CR70","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.exer.2015.03.018","volume":"134","author":"RL Redfern","year":"2015","unstructured":"Redfern RL, Barabino S, Baxter J, Lema C, McDermott AM (2015) Dry eye modulates the expression of toll-like receptors on the ocular surface. Exp Eye Res 134:80\u201389","journal-title":"Exp Eye Res"},{"key":"1913_CR71","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1167\/iovs.17-23397","volume":"59","author":"RY Reins","year":"2018","unstructured":"Reins RY, Lema C, Courson J, Kunnen CME, Redfern RL (2018) MyD88 deficiency protects against dry eye-induced damage. Invest Ophthalmol vis Sci 59:2967\u20132976","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR72","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1167\/iovs.12-9781","volume":"54","author":"J Rieck","year":"2013","unstructured":"Rieck J (2013) The pathogenesis of glaucoma in the interplay with the immune system. Invest Ophthalmol vis Sci 54:2393\u20132409","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR73","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jphs.2017.09.031","volume":"135","author":"K Sakamoto","year":"2017","unstructured":"Sakamoto K, Okuwaki T, Ushikubo H, Mori A, Nakahara T, Ishii K (2017) Activation inhibitors of nuclear factor kappa B protect neurons against the NMDA-induced damage in the rat retina. J Pharmacol Sci 135:72\u201380","journal-title":"J Pharmacol Sci"},{"key":"1913_CR74","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40942-024-00603-y","volume":"10","author":"ASA Sakini","year":"2024","unstructured":"Sakini ASA, Hamid AK, Alkhuzaie ZA, Al-Aish ST, Al-Zubaidi S, Tayem AAE et al (2024) Diabetic macular edema (DME): dissecting pathogenesis, prognostication, diagnostic modalities along with current and futuristic therapeutic insights. Int J Retina Vitreous 10:83","journal-title":"Int J Retina Vitreous"},{"key":"1913_CR75","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41433-024-03015-2","volume":"38","author":"YJ Sepah","year":"2024","unstructured":"Sepah YJ, Do DV, Mesquida M, Day BM, Blotner S, Afridi R et al (2024) Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy. Eye (Lond) 38:1755\u20131761","journal-title":"Eye (Lond)"},{"key":"1913_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-014-2040-4","volume":"393","author":"NK Sharma","year":"2014","unstructured":"Sharma NK, Sharma K, Gupta A, Prabhakar S, Singh R, Gupta PK et al (2014) Does toll-like receptor-3 (TLR-3) have any role in Indian AMD phenotype? Mol Cell Biochem 393:1\u20138","journal-title":"Mol Cell Biochem"},{"key":"1913_CR77","first-page":"704","volume":"20","author":"K Singh","year":"2014","unstructured":"Singh K, Kant S, Singh VK, Agrawal NK, Gupta SK, Singh K (2014) Toll-like receptor 4 polymorphisms and their haplotypes modulate the risk of developing diabetic retinopathy in type 2 diabetes patients. Mol vis 20:704","journal-title":"Mol vis"},{"key":"1913_CR78","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s10792-020-01457-7","volume":"40","author":"T Soni","year":"2020","unstructured":"Soni T, Narang S, Sood S, Tehlan A (2020) Toll-like receptors in acute post-cataract surgery endophthalmitis. Int Ophthalmol 40:2717\u20132725","journal-title":"Int Ophthalmol"},{"key":"1913_CR79","doi-asserted-by":"publisher","first-page":"E3481","DOI":"10.1073\/pnas.1702367114","volume":"114","author":"S Strickson","year":"2017","unstructured":"Strickson S, Emmerich CH, Goh ET, Zhang J, Kelsall IR, Macartney T et al (2017) Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling. Proc Natl Acad Sci U S A 114:E3481\u2013E3489","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"825\u2013832","key":"1913_CR80","volume":"154","author":"Y Takano","year":"2012","unstructured":"Takano Y, Shi D, Shimizu A, Funayama T, Mashima Y, Yasuda N et al (2012) Association of Toll-like receptor 4 gene polymorphisms in Japanese subjects with primary open-angle, normal-tension, and exfoliation glaucoma. Am J Ophthalmol 154(825\u2013832):e1","journal-title":"Am J Ophthalmol"},{"key":"1913_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13050594","author":"Q Tang","year":"2024","unstructured":"Tang Q, Buonfiglio F, B\u00f6hm EW, Zhang L, Pfeiffer N, Korb CA et al (2024) Diabetic retinopathy: new treatment approaches targeting redox and immune mechanisms. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox13050594","journal-title":"Antioxidants (Basel)"},{"key":"1913_CR82","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.exer.2011.06.011","volume":"93","author":"T Tovar-Vidales","year":"2011","unstructured":"Tovar-Vidales T, Clark AF, Wordinger RJ (2011) Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells. Exp Eye Res 93:442\u2013451","journal-title":"Exp Eye Res"},{"key":"1913_CR83","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3390\/ph17091235","volume":"17","author":"F Turgut","year":"2024","unstructured":"Turgut F, Somfai GM, Tappeiner C, Hatz K, Mantel I, Ambresin A et al (2024) Intravitreal dexamethasone implant in anti-vascular endothelial growth factor pretreated diabetic macular edema\u2014a Swiss cohort study. Pharmaceuticals 17:1235","journal-title":"Pharmaceuticals"},{"key":"1913_CR84","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1080\/14712598.2022.2100694","volume":"22","author":"G Uludag","year":"2022","unstructured":"Uludag G, Hassan M, Matsumiya W, Pham BH, Chea S, Trong Tuong Than N et al (2022) Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further? Expert Opin Biol Ther 22:1275\u20131291","journal-title":"Expert Opin Biol Ther"},{"key":"1913_CR85","doi-asserted-by":"publisher","first-page":"9605894","DOI":"10.1155\/2017\/9605894","volume":"2017","author":"TM Vallance","year":"2017","unstructured":"Vallance TM, Zeuner M-T, Williams HF, Widera D, Vaiyapuri S (2017) Toll-like receptor 4 signalling and its impact on platelet function, thrombosis, and haemostasis. Mediators Inflamm 2017:9605894","journal-title":"Mediators Inflamm"},{"key":"1913_CR86","first-page":"2024","volume":"11","author":"A Vitale","year":"2024","unstructured":"Vitale A, Palacios-Olid J, Caggiano V, Ragab G, Hern\u00e1ndez-Rodr\u00edguez J, Pelegr\u00edn L et al (2024) Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries. Front Med 11:2024","journal-title":"Front Med"},{"key":"1913_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/life14060725","author":"L Vitiello","year":"2024","unstructured":"Vitiello L, Salerno G, Coppola A, DE Pascale I, Abbinante G, Gagliardi V et al (2024) Switching to an intravitreal dexamethasone implant after intravitreal anti-VEGF therapy for diabetic macular edema: a review. Life. https:\/\/doi.org\/10.3390\/life14060725","journal-title":"Life"},{"key":"1913_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.maturitas.2013.01.018","volume":"75","author":"VB Voleti","year":"2013","unstructured":"Voleti VB, Hubschman JP (2013) Age-related eye disease. Maturitas 75:29\u201333","journal-title":"Maturitas"},{"key":"1913_CR89","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1021\/tx500216a","volume":"27","author":"H Wang","year":"2014","unstructured":"Wang H, Guo J, West XZ, Bid HK, Lu L, Hong L et al (2014a) Detection and biological activities of carboxyethylpyrrole ethanolamine phospholipids (CEP-EPs). Chem Res Toxicol 27:2015\u20132022","journal-title":"Chem Res Toxicol"},{"key":"1913_CR90","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/858763","volume":"2014","author":"H Wang","year":"2014","unstructured":"Wang H, Shi H, Zhang J, Wang G, Zhang J, Jiang F et al (2014b) Toll-like receptor 4 in bone marrow-derived cells contributes to the progression of diabetic retinopathy. Mediators Inflamm 2014:858763","journal-title":"Mediators Inflamm"},{"key":"1913_CR91","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/970156","volume":"2015","author":"J Wang","year":"2015","unstructured":"Wang J, Sun Z, Shen J, Wu D, Liu F, Yang R et al (2015) Octreotide protects the mouse retina against ischemic reperfusion injury through regulation of antioxidation and activation of NF-\u03baB. Oxid Med Cell Longev 2015:970156","journal-title":"Oxid Med Cell Longev"},{"key":"1913_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.781616","volume":"8","author":"B Wang","year":"2021","unstructured":"Wang B, Zeng H, Zuo X, Yang X, Wang X, He D et al (2021) TLR4-dependent DUOX2 activation triggered oxidative stress and promoted HMGB1 release in dry eye. Front Med (Lausanne) 8:781616","journal-title":"Front Med (Lausanne)"},{"key":"1913_CR93","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106\u2013e116","journal-title":"Lancet Glob Health"},{"key":"1913_CR94","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2023.12.026","volume":"131","author":"TY Wong","year":"2024","unstructured":"Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N et al (2024) Faricimab treat-and-extend for diabetic macular edema: two-year results from the randomized phase 3 YOSEMITE and RHINE trials. Ophthalmology 131:708\u2013723","journal-title":"Ophthalmology"},{"key":"1913_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092043","author":"Y Wu","year":"2023","unstructured":"Wu Y, Xie Y, Yuan Y, Xiong R, Hu Y, Ning K et al (2023) The mediterranean diet and age-related eye diseases: a systematic review. Nutrients. https:\/\/doi.org\/10.3390\/nu15092043","journal-title":"Nutrients"},{"key":"1913_CR96","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s10637-024-01464-w","volume":"42","author":"Z Wu","year":"2024","unstructured":"Wu Z, Sun W, Wang C (2024) Clinical characteristics, treatment, and outcomes of pembrolizumab-induced uveitis. Invest New Drugs 42:510\u2013517","journal-title":"Invest New Drugs"},{"key":"1913_CR97","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1515\/revneuro-2014-0067","volume":"26","author":"W Xiang","year":"2015","unstructured":"Xiang W, Chao Z-Y, Feng D-Y (2015) Role of toll-like receptor\/MYD88 signaling in neurodegenerative diseases. Rev Neurosci 26:407\u2013414","journal-title":"Rev Neurosci"},{"key":"1913_CR98","doi-asserted-by":"publisher","first-page":"14357","DOI":"10.1080\/21655979.2022.2085391","volume":"13","author":"W Xie","year":"2022","unstructured":"Xie W, Yu Q, Wang L, Shao Y, Bo Q, Wu G (2022) Toll-like receptor 3 gene regulates cataract-related mechanisms via the Jagged-1\/Notch signaling pathway. Bioengineered 13:14357\u201314367","journal-title":"Bioengineered"},{"key":"1913_CR99","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/bjophthalmol-2015-306677","volume":"99","author":"Y Xu","year":"2015","unstructured":"Xu Y, Jiang Z, Huang J, Meng Q, Coh P, Tao L (2015) The association between toll-like receptor 4 polymorphisms and diabetic retinopathy in Chinese patients with type 2 diabetes. Br J Ophthalmol 99:1301\u20131305","journal-title":"Br J Ophthalmol"},{"key":"1913_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080288","volume":"8","author":"Y Yang","year":"2013","unstructured":"Yang Y, Takeda A, Yoshimura T, Oshima Y, Sonoda K-H, Ishibashi T (2013) IL-10 is significantly involved in HSP70-regulation of experimental subretinal fibrosis. PLoS ONE 8:e80288","journal-title":"PLoS ONE"},{"key":"1913_CR101","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41401-020-0484-5","volume":"42","author":"F-M Yang","year":"2021","unstructured":"Yang F-M, Fan D, Yang X-Q, Zhu F-H, Shao M-J, Li Q et al (2021) The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4\/NF-\u03baB\/NLRP3 signaling. Acta Pharmacol Sin 42:593\u2013603","journal-title":"Acta Pharmacol Sin"},{"key":"1913_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054676","author":"JY Yang","year":"2023","unstructured":"Yang JY, Goldberg D, Sobrin L (2023) Interleukin-6 and macular edema: a review of outcomes with inhibition. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24054676","journal-title":"Int J Mol Sci"},{"key":"1913_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2025.117408","volume":"279","author":"Y Ye","year":"2025","unstructured":"Ye Y, Lu Y, Su H, Tian Y, Jin S, Li G et al (2025) A hybrid bioelectronic retina-probe interface for object recognition. Biosens Bioelectron 279:117408","journal-title":"Biosens Bioelectron"},{"key":"1913_CR104","doi-asserted-by":"publisher","first-page":"1449985","DOI":"10.3389\/fphar.2024.1449985","volume":"15","author":"X Yuan","year":"2024","unstructured":"Yuan X, Zhang Y, Wang S, Du Z (2024a) Protective effects of insulin on dry eye syndrome via TLR4\/NF-\u03baB pathway: based on network pharmacology and in vitro experiments validation. Front Pharmacol 15:1449985","journal-title":"Front Pharmacol"},{"key":"1913_CR105","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fphar.2024.1449985","volume":"15","author":"X Yuan","year":"2024","unstructured":"Yuan X, Zhang Y, Wang S, Du Z (2024b) Protective effects of insulin on dry eye syndrome via TLR4\/NF-\u03baB pathway: based on network pharmacology and in vitro experiments validation. Front Pharmacol 15:2024","journal-title":"Front Pharmacol"},{"key":"1913_CR106","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/iub.2413","volume":"73","author":"P Zafari","year":"2021","unstructured":"Zafari P, Golpour M, Hafezi N, Bashash D, Esmaeili SA, Tavakolinia N et al (2021) Tuberculosis comorbidity with rheumatoid arthritis: gene signatures, associated biomarkers, and screening. IUBMB Life 73:26\u201339","journal-title":"IUBMB Life"},{"key":"1913_CR107","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1515\/enr-2017-0014","volume":"51","author":"E Zaharieva","year":"2017","unstructured":"Zaharieva E, Kamenov Z, Savov A (2017) TLR4 polymorphisms seem not to be associated with prediabetes and type 2 diabetes but predispose to diabetic retinopathy; TLR4 polymorphisms in glucose continuum. Endocr Regul 51:137\u2013144","journal-title":"Endocr Regul"},{"key":"1913_CR108","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1167\/iovs.18-25572","volume":"60","author":"X Zhang","year":"2019","unstructured":"Zhang X, Yin Y, Yue L, Gong L (2019) Selective serotonin reuptake inhibitors aggravate depression-associated dry eye via activating the NF-\u03baB pathway. Invest Ophthalmol vis Sci 60:407\u2013419","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1913_CR109","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202011_23575","author":"P-P Zhang","year":"2020","unstructured":"Zhang P-P, Cao X-N, Ren L (2020) Associations of toll-like receptor 3 gene single nucleotide polymorphisms with cataract. Eur Rev Med Pharmacol Sci. https:\/\/doi.org\/10.26355\/eurrev_202011_23575","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1913_CR110","doi-asserted-by":"publisher","first-page":"16852","DOI":"10.1038\/s41598-025-00638-7","volume":"15","author":"C Zhang","year":"2025","unstructured":"Zhang C, Sim\u00f3n M, Harder JM, Lim H, Montgomery C, Wang Q et al (2025) Tlr4 deficiency does not alter glaucomatous progression in a mouse model of chronic glaucoma. Sci Rep 15:16852","journal-title":"Sci Rep"},{"key":"1913_CR111","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1096\/fj.11-189258","volume":"25","author":"P Zhou","year":"2011","unstructured":"Zhou P, Fan L, Yu KD, Zhao MW, Li XX (2011) Toll-like receptor 3 C1234T may protect against geographic atrophy through decreased dsRNA binding capacity. FASEB J 25:3489\u20133495","journal-title":"FASEB J"},{"key":"1913_CR112","first-page":"1826","volume":"19","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Liang L, Qian D, Yu H, Yang P, Lei B et al (2013) Increase in peripheral blood mononuclear cell toll-like receptor 2\/3 expression and reactivity to their ligands in a cohort of patients with wet age-related macular degeneration. Mol vis 19:1826","journal-title":"Mol vis"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01913-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01913-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01913-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:02:57Z","timestamp":1758085377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01913-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":112,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01913-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"It is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI using"}}]}}